1-4 of 4
Ozden Hatirnaz Ng, PhD
Close
Sort by
Journal Articles

IKZF1 Deletions at Diagnose and Relapse of Childhood B-ALL

Yücel Erbilgin, Sinem Firtina, PhD, Ozden Hatirnaz Ng, PhD, Tiraje Celkan, MD, Zeynep Karakas, MD, Seniye Sema Anak, MD, Nazan Sarper, MD, Emine Zengin, MD, Ahmet Eskazan, MD, Muge Sayitoglu, PhD, Ugur Ozbek, MD, PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 5110.
https://doi.org/10.1182/blood.V130.Suppl_1.5110.5110
Published: 2017
Journal Articles

New CNV Regions Identified in ITP Provide Evidence for Genetic Predisposition

M. Cem Ar, MD PhD, Emrah Yucesan, PhD, Firat Yalniz, MD, Ozden Hatirnaz Ng, PhD, Ayse Salihoglu, MD, Selin Berk, MD, Ahmet Emre Eskazan, MD, Seniz Ongoren, MD Associated Proffessor, Zafer Baslar, MD, Ugur Ozbek, MD PhD, Teoman Soysal, MD, Yildiz Aydin, MD, Muge Sayitoglu, PhD
Journal: Blood
Blood (2015) 126 (23): 77.
https://doi.org/10.1182/blood.V126.23.77.77
Published: 2015
Journal Articles

Genetic and Epigenetic Profile Of Early Relapsed Childhood ALL

Yucel Erbilgin, Ozden Hatirnaz Ng, PhD, Sinem Firtina, Tiraje Celkan, Sema Anak, MD, Zeynep Karakas, MD, Aykan Ozguven, MD, Nazan Sarper, MD, Emine Zengin, MD, Emine Turkkan, MD, Didem Yalcin Atay, MD, Yuk Yin Ng, PhD, Omer Dogru, MD, Muge Sayitoglu, PhD, Ugur Ozbek
Journal: Blood
Blood (2013) 122 (21): 1380.
https://doi.org/10.1182/blood.V122.21.1380.1380
Published: 2013
Journal Articles

Next-Generation Sequencing Of The BCR-ABL1 Kinase Domain May Be Beneficial In Decision Making Among Chronic Myeloid Leukemia Patients With Tyrosine Kinase Inhibitor Resistance

Yucel Erbilgin, Ahmet Emre Eskazan, Ozden Hatirnaz Ng, PhD, Ayse Salihoglu, Tugrul Elverdi, MD, Sinem Firtina, Suzin Catal Tatonyan, Seniz Ongoren Aydin, Muhlis Cem Ar, Zafer Baslar, Muge Sayitoglu, PhD, A. Burhan Ferhanoglu, Yildiz Aydin, Ugur Ozbek, Teoman Soysal
Journal: Blood
Blood (2013) 122 (21): 384.
https://doi.org/10.1182/blood.V122.21.384.384
Published: 2013